Symplmed Pharmaceuticals is a privately held pharmaceutical company optimizing the value of its medicines and those of its industry partners by streamlining the prescription process, from fulfillment and payment to therapeutic compliance and outcomes monitoring.
Our patented technology platform, DyrctAxess™, enables direct delivery of medications to a patient’s home and eliminates the problem of unfilled prescriptions. By providing shared access to real-time information about medication use and its efficacy, DyrctAxess helps patients, physicians and manufacturers achieve optimal care.
Symplmed is taking a therapeutic area approach, ensuring that medications necessary to manage a particular disease state are available through its DyrctAxess platform. The Company’s initial focus is high blood pressure (hypertension) with proprietary Prestalia®, a single-pill, fixed-dose combination (FDC) of perindopril arginine and amlodipine besylate. Symplmed also plans to expand its pipeline in multiple therapeutic areas.
Our mission is to optimize the value of prescription medicines by streamlining the treatment process. Our patented technology platform puts more control and more information into the hands of patients, physicians and manufacturers to improve compliance and outcomes. The end result is simply better care.